, Tracking Stock Market Picks
Enter Symbol:
Rating: SGNT
Buy $25

Sagent Pharmaceuticals Inc. (NASDAQ: SGNT) reiterated to Buy with price target $25 by Needham

Wednesday,  Aug 7, 2013  8:25 AM ET by Dave Ficere

Needham reiterated Sagent Pharmaceuticals Inc. (NASDAQ: SGNT) to Buy with price
target $25. Previously Needham rated Buy with price target $20 Sagent Pharmaceuticals Inc. (NASDAQ: SGNT) on 08/10/2012, when the stock price was $13.21.

Needham & Company, LLC focuses on emerging growth companies in technology, biotechnology and life sciences. The firm's research goal is to service the needs of growth-oriented institutional clients. Needham & Company has established itself as a premier specialty investment bank providing timely and valuable analysis on companies that are under-covered by the majority of Wall Street firms.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy